NEU (ASX) Share Price

Originally posted by hottod: ↑

Valproate is one of the most commonly prescribed medications for epileptic seizures suffered by individuals with Rett syndrome. Valproate products have been approved by the FDA.

Information on some of the more serious and more common adverse events associated with use of valproate products are listed below.

Anyone worried about the side effect profile of trofinetide should have a read.

Valproic acid may cause serious or life-threatening damage to the liver that is most likely to occur within the first 6 months of therapy.

Valproic acid can cause serious birth defects (physical problems that are present at birth), especially affecting the brain and spinal cord and can also cause lower intelligence and problems with movement and coordination, learning, communication, emotions, and behavior in babies exposed to valproic acid before birth.

Valproic acid may cause serious or life-threatening damage to the pancreas. This may occur at any time during your treatment.

Valproic acid may help to control your condition but will not cure it. Continue to take valproic acid even if you feel well. Do not stop taking valproic acid without talking to your doctor, even if you experience side effects such as unusual changes in behavior or mood or if you find out that you are pregnant. If you suddenly stop taking valproic acid, you may experience a severe, long-lasting and possibly life-threatening seizure. Your doctor will probably decrease your dose gradually.

https://medlineplus.gov/druginfo/meds/a682412.html

Cardiovascular
Common (1% to 10%): Edema, hypertension, hypotension, palpitations postural hypotension, peripheral edema, tachycardia, vasodilation

Psychiatric
Very common (10% or more): Nervousness
Common (1% to 10%): Abnormal dreams, agitation, anxiety, aggression, confusion, depression, emotional lability, hallucinations, insomnia, personality disorder, thinking abnormalities

Respiratory
Very common (10% or more): Flu syndrome, respiratory infection
Common (1% to 10%): Bronchitis, dyspnea, epistaxis, increased cough, pharyngitis, pneumonia, rhinitis, sinusitis

Dermatologic
Very common (10% or more): Alopecia
Common (1% to 10%): Discoid lupus erythematosus, dry skin, ecchymosis, furunculosis, maculopapular rash, petechia, pruritus, rash, seborrhea

Gastrointestinal
Very common (10% or more): Abdominal pain, diarrhea, dyspepsia, gingival disorder, nausea, vomiting
Common (1% to 10%): Constipation, dry mouth, eructation, fecal incontinence, flatulence, gastralgia, gastroenteritis, glossitis, periodontal abscess, hematemesis, stomatitis

Genitourinary
Common (1% to 10%): Amenorrhea, cystitis, dysmenorrhea, dysuria, enuresis, metrorrhagia, urinary incontinence, urinary frequency, vaginal hemorrhage, vaginitis

Hematologic
Very common (10% or more): Thrombocytopenia
Common (1% to 10%): Anemia, hemorrhage

Hepatic
Common (1% to 10%): Increased liver enzymes (particularly early in treatment), liver injury, SGOT increased, SGPT increased

Local
Common (1% to 10%): Injection site pain, injection site reaction

Metabolic
Very common (10% or more): Anorexia
Common (1% to 10%): Weight loss/gain, increased appetite, hyponatremia

Musculoskeletal
Common (1% to 10%): Arthralgia, arthrosis, leg cramps, myalgia, myasthenia, twitching

Nervous system
Very common (10% or more): Dizziness, headache, somnolence, tremor
Common (1% to 10%): Abnormal gait, amnesia, catatonic reaction, convulsion, disturbance in attention, dysarthria, extrapyramidal disorder, hypertonia, hypokinesia, incoordination, increased reflexes, memory impairment, nystagmus, paraesthesia, speech disorder, stupor, tardive dyskinesia, taste perversion

Ocular
Very common (10% or more): Amblyopia/blurred vision, diplopia
Common (1% to 10%): Abnormal vision, conjunctivitis, diplopia, dry eyes, eye pain

Other
Very common (10% or more): Asthenia
Common (1% to 10%): Back pain, chills, deafness, ear disorder, ear pain, face edema, fever, malaise, otitis media, tinnitus, vertigo

https://www.drugs.com/sfx/valproate-sodium-side-effects.html#consumer

Expand

Those poor girls having to deal with that on top of Retts, as part of treatment!

Does anyone know, off hand, how much seizures reduced with Trof?

I hope a lot.

.

No.	Vol.	Price($)
1	1588	$13.01

No.

Vol.

Price($)

1588

$13.01

Price($)	Vol.	No.
$13.06	1000	1

Price($)

Vol.

No.

$13.06

1000

No.	Vol.	Price($)
1	1588	13.010
2	1422	13.000
2	3500	12.980
4	4561	12.960
5	5049	12.950

No.

Vol.

Price($)

1588

13.010

1422

13.000

3500

12.980

4561

12.960

5049

12.950

Price($)	Vol.	No.
13.060	1000	1
13.070	1709	2
13.080	2082	1
13.100	2082	1
13.120	2082	1

Price($)

Vol.

No.

13.060

1000

13.070

1709

13.080

2082

13.100

2082

13.120

2082

(20min delay)
Last $13.02		Change 0.080(0.62%)		Mkt cap ! $1.664B

Open	High	Low	Value	Volume
$13.23	$13.35	$12.99	$5.557M	423.2K

Share Price, page-2176

Lincoln Minerals to kick off fieldwork at Yallunda uranium project in the nuclear state, SA

True North shares jump on positive activity report as Cloncurry aims for Q1 production deadline

Quantum Graphite snags new exploration licence in SA ahead of maiden drilling

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Woomera kicks off 2-pronged drilling at Mongolia's Bronze Fox Cu-Au play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Share Price, page-2176

Top Stories

Lincoln Minerals to kick off fieldwork at Yallunda uranium project in the nuclear state, SA

True North shares jump on positive activity report as Cloncurry aims for Q1 production deadline

Quantum Graphite snags new exploration licence in SA ahead of maiden drilling

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Woomera kicks off 2-pronged drilling at Mongolia's Bronze Fox Cu-Au play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News